Compare Oracle Corporation (ORCL) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oracle Corporation vs Tenet Healthcare Corporation — how do they compare? Oracle Corporation trades at $126.98 (market cap $365.96B), while Tenet Healthcare Corporation trades at $195.35 (market cap $16.93B). The key difference: Oracle Corporation is far larger — about 21.6× Tenet Healthcare Corporation's market cap, and Oracle Corporation pays a 1.57% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| ORCL | THC | |
|---|---|---|
Market Cap | $365.96B | $16.93B |
Sector | Technology | Health |
52-Week High | $328.33 | $244.80 |
52-Week Low | $121.37 | $148.38 |
Enterprise Value | $495.21B | $27.17B |
Dividend Yield | 1.57% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Oracle (ORCL) is trading at $121.37, down 4.04% today, reflecting recent market volatility. The stock shows strong fundamentals with consistent earnings beats (Q3 2025-Q1 2026) and robust profitability metrics including 65.82% gross margin and 58.56% ROE. Technical indicators are mixed with a bearish moving average signal but bullish RSI readings. Recent news highlights Oracle's AI infrastructure expansion and partnership with OpenAI, driving investor interest despite concerns about capital requirements.
Oracle presents a compelling investment case with strong analyst support (65% buy ratings) and a $253.30 consensus price target representing significant upside. Key opportunities include AI-driven growth and cloud expansion, while risks involve high debt levels ($92.6B total liabilities) and competitive pressures in enterprise software. The upcoming Q2 2026 earnings report on June 10 will be critical for validating the AI growth narrative.
Tenet Healthcare (THC) trades at $194.38, down 0.27% on the day, with a bearish technical signal but strong fundamentals. The stock has beaten EPS estimates for three consecutive quarters, with a Q2 2026 report due July 24. Valuation metrics appear attractive with a P/E of 10.11 and P/S of 0.79. Revenue and net income are projected to grow in 2026, supported by expansion in outpatient care.
The outlook is positive given analyst consensus with 81% buy ratings and a $234.63 price target, implying 21% upside. Risks include potential pressure from lower patient days and high debt levels. Earnings growth and ambulatory care performance remain key catalysts for near-term momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oracle Corporation
Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.
Read more on ORCL →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
